{"id":"W3201749259","doi":"10.51731/cjht.2021.150","title":"Encorafenib in Combination With Binimetinib (Braftovi and Mektovi)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Metastatic melanoma; Medicine; Business; Test (biology); Marketing; Melanoma; Economic growth; Economics; Cancer research; Health care","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002746529,0.00007435134,0.0001620564,0.0001889446,0.0000653588,0.00001758344,0.0001064053,0.0001127479,0.000004178441],"category_scores_gemma":[0.0002447055,0.0000634126,0.00001855754,0.0001599447,0.00009847004,0.000005262299,0.00001887694,0.0001505244,5.348352e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003701893,"about_ca_system_score_gemma":0.001670204,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004591051,"about_ca_topic_score_gemma":0.009639872,"domain_scores_codex":[0.9993246,0.00005033633,0.0002342403,0.0001206811,0.00005709512,0.0002130264],"domain_scores_gemma":[0.9995432,0.0000102588,0.0001458337,0.0001351191,0.0001085485,0.00005699275],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009716744,0.0001034116,0.1726627,0.000234726,0.00008503669,0.0009302536,0.0004567131,0.00002930893,0.04068869,0.005853281,0.003966973,0.7748917],"study_design_scores_gemma":[0.004395593,0.004905233,0.1079776,0.0005067329,0.00002136849,0.003096818,0.009454341,0.00001712071,0.2614904,0.006043593,0.6014981,0.0005931095],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9605218,0.03284309,0.0003156943,0.005866774,0.0000940769,0.00007649919,0.000007049596,0.000008269149,0.0002667459],"genre_scores_gemma":[0.9978467,0.0007142192,0.001160783,0.0002050634,0.000006474876,0.00000245624,0.000008518933,0.000007072403,0.00004873704],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7742986,"threshold_uncertainty_score":0.5379275,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01264713516165927,"score_gpt":0.2332894311798047,"score_spread":0.2206422960181455,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}